肾素作为危重症患者组织灌注标志物与预后指标
这项前瞻性观察研究在单中心混合内外科ICU纳入20例成人患者(脓毒性休克30%、失血性休克15%、心源性休克20%、无循环休克35%),从动脉导管和连续性肾脏替代治疗管路每6小时采血直接测定血浆肾素,共112份动脉样本,ICU死亡率为30%。肾素与尿量(重复测量相关系数-0.29,p=0.015)和平均动脉压(重复测量相关系数-0.35,p<0.001)显著相关,未发现昼夜变异或肾素-血管紧张素-醛固酮系统药物的显著交互作用,连续性肾脏替代治疗对肾素的清除可忽略(质量清除率4%±4.3%)。幸存者与死亡者肾素随时间变化率有显著差异(-32±26 μU/时间点 vs +92±57 μU/时间点,p=0.03),乳酸则无显著差异(-0.14±0.04 mM/时间点 vs +0.15±0.21 mM/时间点,p=0.07)。最大肾素对ICU死亡有显著预后价值(ROC曲线下面积0.80,p=0.04),最大乳酸则无(ROC曲线下面积0.70,p=0.17)。
要点
- 在混合ICU人群中,肾素与尿量(重复测量相关系数-0.29,p=0.015)和平均动脉压(重复测量相关系数-0.35,p<0.001)显著相关,提示其可作为组织灌注标志物。
- 幸存者肾素随时间变化率为-32±26 μU/时间点,死亡者为+92±57 μU/时间点,两者差异显著(p=0.03);乳酸变化率在两组间无显著差异(-0.14±0.04 mM/时间点 vs +0.15±0.21 mM/时间点,p=0.07)。
- 最大肾素对ICU死亡的ROC曲线下面积为0.80(p=0.04),最大乳酸为0.70(p=0.17),肾素预测价值优于乳酸。
- 肾素测定未发现昼夜变异,肾素-血管紧张素-醛固酮系统药物无显著交互作用,连续性肾脏替代治疗对肾素清除可忽略(质量清除率4%±4.3%)。
适用人群与场景
- 年龄超过18岁、基线估算肾小球滤过率大于30 mL/min/1.73 m、预期ICU停留时间大于24小时的成人患者,来自单中心混合内外科ICU。
- 研究纳入的循环状态包括脓毒性休克(30%)、失血性休克(15%)、心源性休克(20%)和无循环休克(35%)。
研究设计与关键结果
- 前瞻性观察研究,单中心混合内外科ICU,纳入20例患者(65%男性,平均±标准差60±14岁),共采集112份动脉样本,ICU死亡率为30%。
- 肾素与尿量呈负相关(重复测量相关系数-0.29,p=0.015),与平均动脉压呈负相关(重复测量相关系数-0.35,p<0.001)。
- 未发现肾素昼夜变异,肾素-血管紧张素-醛固酮系统药物与肾素无显著交互作用,连续性肾脏替代治疗对肾素质量清除率为4%±4.3%。
- 幸存者肾素随时间变化率为-32±26 μU/时间点,死亡者为+92±57 μU/时间点,差异显著(p=0.03);乳酸变化率幸存者为-0.14±0.04 mM/时间点,死亡者为+0.15±0.21 mM/时间点,无显著差异(p=0.07)。
- 最大肾素预测ICU死亡的ROC曲线下面积为0.80(p=0.04),最大乳酸为0.70(p=0.17)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在混合ICU人群中,直接血浆肾素测定可不受昼夜节律、连续性肾脏替代治疗或肾素-血管紧张素-醛固酮系统药物的显著影响,可作为组织灌注的标志物。
- 肾素随时间的变化趋势及最大肾素值可用于辅助预测ICU死亡,且预测价值优于乳酸。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To characterize renin in critically ill patients. Renin is fundamental to circulatory homeostasis and could be a useful marker of tissue-perfusion. However, diurnal variation, continuous renal replacement therapy and drug-interference could confound its use in critical care practice.
DESIGN: Prospective observational study.
SETTING: Single-center, mixed medical-surgical ICU in Europe.
PATIENTS: Patients over 18 years old with a baseline estimated glomerular filtration rate greater than 30 mL/min/1.73 m and anticipated ICU stay greater than 24 hours. Informed consent was obtained from the patient or next-of-kin.
INTERVENTIONS: Direct plasma renin was measured in samples drawn 6-hourly from arterial catheters in recumbent patients and from extracorporeal continuous renal replacement therapy circuits. Physiologic variables and use of drugs that act on the renin-angiotensin-aldosterone system were recorded prospectively. Routine lactate measurements were used for comparison.
MEASUREMENTS AND MAIN RESULTS: One-hundred twelve arterial samples (n = 112) were drawn from 20 patients (65% male; mean ± SD, 60 ± 14 yr old) with septic shock (30%), hemorrhagic shock (15%), cardiogenic shock (20%), or no circulatory shock (35%). The ICU mortality rate was 30%. Renin correlated significantly with urine output (repeated-measures correlation coefficient = -0.29; p = 0.015) and mean arterial blood pressure (repeated-measures correlation coefficient = -0.35; p < 0.001). There was no diurnal variation of renin or significant interaction of renin-angiotensin-aldosterone system drugs with renin in this population. Continuous renal replacement therapy renin removal was negligible (mass clearance ± SD 4% ± 4.3%). There was a significant difference in the rate of change of renin over time between survivors and nonsurvivors (-32 ± 26 μU/timepoint vs +92 ± 57 μU/timepoint p = 0.03; mean ± SEM), but not for lactate (-0.14 ± 0.04 mM/timepoint vs +0.15 ± 0.21 mM/timepoint; p = 0.07). Maximum renin achieved significant prognostic value for ICU mortality (receiver operator curve area under the curve 0.80; p = 0.04), whereas maximum lactate did not (receiver operator curve area under the curve, 0.70; p = 0.17).
CONCLUSIONS: In an heterogeneous ICU population, renin measurement was not significantly affected by diurnal variation, continuous renal replacement therapy, or drugs. Renin served as a marker of tissue-perfusion and outperformed lactate as a predictor of ICU mortality.
参考来源
- Gleeson PJ, Crippa IA, Mongkolpun W, et al. Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients. Crit Care Med. 2019. PMID: 30653055. doi:10.1097/CCM.0000000000003544
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。